Replicel Life Sciences Inc
XTSX:RP

Watchlist Manager
Replicel Life Sciences Inc Logo
Replicel Life Sciences Inc
XTSX:RP
Watchlist
Price: 0.01 CAD -33.33% Market Closed
Market Cap: 636.6k CAD
Have any thoughts about
Replicel Life Sciences Inc?
Write Note

Replicel Life Sciences Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Replicel Life Sciences Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABCL
ARCH
IOT

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Replicel Life Sciences Inc
XTSX:RP
Cash from Operating Activities
-CA$2m
CAGR 3-Years
-16%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Abcellera Biologics Inc
NASDAQ:ABCL
Cash from Operating Activities
-$43.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Cash from Operating Activities
-CA$2.7m
CAGR 3-Years
14%
CAGR 5-Years
-6%
CAGR 10-Years
-26%
Innovotech Inc
XTSX:IOT
Cash from Operating Activities
-CA$299.3k
CAGR 3-Years
N/A
CAGR 5-Years
-16%
CAGR 10-Years
-14%

See Also

What is Replicel Life Sciences Inc's Cash from Operating Activities?
Cash from Operating Activities
-2m CAD

Based on the financial report for Sep 30, 2023, Replicel Life Sciences Inc's Cash from Operating Activities amounts to -2m CAD.

What is Replicel Life Sciences Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-10%

Over the last year, the Cash from Operating Activities growth was -18%. The average annual Cash from Operating Activities growth rates for Replicel Life Sciences Inc have been -16% over the past three years , -10% over the past five years .

Back to Top